Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Sexton

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Emerging Infectious Diseases|February 19, 2026
Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022-2023Jessica E Laury, Kaitlin Forsberg, Elizabeth L Berkow, et al.
Annals of the Rheumatic Diseases|December 5, 2023
Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC studyValeriia Melokhina, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
BMC Sports Science, Medicine & Rehabilitation|April 21, 2023
Associations between cardiovascular risk factors, disease activity and cardiorespiratory fitness in patients with inflammatory joint disease: a cross-sectional analysisKristine Røren Nordén, Anne Grete Semb, Hanne Dagfinrud, et al.
RMD Open|January 12, 2024
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activityKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
BMJ Open|February 18, 2022
Effect of high-intensity exercise on cardiorespiratory fitness, cardiovascular disease risk and disease activity in patients with inflammatory joint disease: protocol for the ExeHeart randomised controlled trialKristine Røren Nordén, Hanne Dagfinrud, Anne Grete Semb, et al.
Journal of Clinical Epidemiology|December 10, 2023
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaborationCelina K Gehringer, Glen P Martin, Kimme L Hyrich, et al.
RMD Open|February 6, 2021
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategyUlf Sundin, Nina Paulshus Sundlisater, Anna-Birgitte Aga, et al.
Annals of the Rheumatic Diseases|July 23, 2017
Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD studyBrigitte Michelsen, Eirik Klami Kristianslund, Joseph Sexton, et al.
RMD Open|January 19, 2024
Effect of high-intensity interval training in physiotherapy primary care for patients with inflammatory arthritis: the ExeHeart randomised controlled trialKristine Røren Nordén, Anne Grete Semb, Hanne Dagfinrud, et al.
Annals of the Rheumatic Diseases|January 31, 2026
Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritisGina Hetland Brinkmann, Nina Paulshus Sundlisæter, Lena Bugge Nordberg, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Emerging Infectious Diseases|February 19, 2026
Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022-2023Jessica E Laury, Kaitlin Forsberg, Elizabeth L Berkow, et al.
Annals of the Rheumatic Diseases|December 5, 2023
Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC studyValeriia Melokhina, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
BMC Sports Science, Medicine & Rehabilitation|April 21, 2023
Associations between cardiovascular risk factors, disease activity and cardiorespiratory fitness in patients with inflammatory joint disease: a cross-sectional analysisKristine Røren Nordén, Anne Grete Semb, Hanne Dagfinrud, et al.
RMD Open|January 12, 2024
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activityKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
BMJ Open|February 18, 2022
Effect of high-intensity exercise on cardiorespiratory fitness, cardiovascular disease risk and disease activity in patients with inflammatory joint disease: protocol for the ExeHeart randomised controlled trialKristine Røren Nordén, Hanne Dagfinrud, Anne Grete Semb, et al.
Journal of Clinical Epidemiology|December 10, 2023
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaborationCelina K Gehringer, Glen P Martin, Kimme L Hyrich, et al.
RMD Open|February 6, 2021
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategyUlf Sundin, Nina Paulshus Sundlisater, Anna-Birgitte Aga, et al.
Annals of the Rheumatic Diseases|July 23, 2017
Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD studyBrigitte Michelsen, Eirik Klami Kristianslund, Joseph Sexton, et al.
RMD Open|January 19, 2024
Effect of high-intensity interval training in physiotherapy primary care for patients with inflammatory arthritis: the ExeHeart randomised controlled trialKristine Røren Nordén, Anne Grete Semb, Hanne Dagfinrud, et al.
Annals of the Rheumatic Diseases|January 31, 2026
Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritisGina Hetland Brinkmann, Nina Paulshus Sundlisæter, Lena Bugge Nordberg, et al.
Pageof 14